Tracking metabolic reprogramming through stable isotope-resolved metabolomics
Tracking metabolic reprogramming through stable isotope-resolved metabolomics
批准号:
MR/X013715/1
负责人:
George Poulogiannis
金额:
$49.8万
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2022
资助国家:
英国
项目状态:
已结题
起止时间:
2022 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Evidence suggests that the way cells consume and process nutrients, collectively known as metabolism, differs between healthy and diseased cells and can even change the way they communicate with adjacent cells, survive and grow. Changes in metabolism are very important in protecting us against dangers such as infections or cancer, but have also been implicated in neurodegenerative diseases and metabolic disorders such as obesity, type 2 diabetes, and metabolic syndrome. Both systemic and local metabolic alterations can also affect drug response and the acquisition of antibiotic or anti-cancer drug resistance. This project will draw on the strengths of acquiring and setting up a specialised equipment known as mass spectrometer capable of determining the mass of analytes based on the motion of ions in electric and magnetic fields. Through setting up assays to measure different classes of core metabolites (e.g. amino acids, carbohydrates, nucleotides, lipids etc.) the first objective of this proposal is to provide the capability to track the rewiring of metabolism in the context of infection, immunity, metabolic disorders and cancer, and their organism-wide implications across different organs and tissues. This will assist with gaining insight into the metabolic interplay between host immune cells and pathogens or cancer cells and how these interactions ultimately affect disease outcomes. The second objective of this proposal is, to exploit metabolic profiles to identify more effective predictors of response to therapy and unveil novel metabolic dependencies and vulnerabilities. This approach will not only provide novel mechanistic insights of disease pathogenesis, but could also enable biomarker discovery of metabolites that predict pathogenic processes and the response to targeted or untargeted therapies. In the longer term this knowledge will help identify weaknesses in the pathogen or the tumour's armour and ultimately unveil more effective therapeutic strategies where diet and metabolic targets could empower our body to better defend attacks by "foreign" invaders.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Innovative metabolic mapping to predict and enhance the response of targeted anti-cancer therapies
-
批准号:MR/W012030/1
-
项目类别:Fellowship
-
资助金额:$192.26万
-
财政年份:2022
-
负责人:George Poulogiannis
-
依托单位:
国内基金
海外基金
登录
查看更多内容
α-酮戊二酸调控ACMSD介导犬尿氨酸通路代谢重编程在年龄相关性听力损失中的作用及机制研究
-
批准号:82371150
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:侯书乐
-
依托单位:
多囊卵巢综合征中甲酰肽受体2调控小胶质细胞代谢重编程导致GnRH神经元过度激活及HPO轴异常的病理机制研究
-
批准号:82370797
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:陶弢
-
依托单位:
NPC1调控肾上腺皮质激素分泌影响代谢稳态的机制研究
-
批准号:82370796
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:蒋怡然
-
依托单位:
衰老上皮细胞FABP4调控HSDL2致脂肪酸代谢失衡在BPH发病中的机制研究
-
批准号:82370774
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:阮渊
-
依托单位:
基于AMPK/PGC-1α信号轴的工程化外泌体靶向调控BMSCs能量代谢重编程在老年机体骨修复中的作用及其机制研究
-
批准号:82370920
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:周名亮
-
依托单位:
基于影像代谢重塑可视化的延胡索酸水合酶缺陷型肾癌危险性分层模型的研究
-
批准号:82371912
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:吴广宇
-
依托单位:
GPSM1介导Ca2+循环-II型肌球蛋白网络调控脂肪产热及代谢稳态的机制研究
-
批准号:82370879
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:严婧
-
依托单位:
PRRC2在eIF3调控的翻译过程中的分子机制及其对肌肉健康的影响
-
批准号:32100620
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:林英英
-
依托单位:
SLC38A6通过调控天冬氨酸介导的嘧啶合成促进肝癌生长的机制研究
-
批准号:32100626
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:秦望舒
-
依托单位:
溶酶体贮积症细胞内胆固醇累积导致患者神经元死亡的细胞与分子机制
-
批准号:32100621
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:李平
-
依托单位: